mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
2e-06 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
3e-06 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-06 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-06 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
3e-06 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.34 |
4e-06 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
4e-06 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-06 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
4e-06 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |